资本市场投资者保护再升级 最高法将制定两部民事赔偿司法解释

Core Viewpoint - The Supreme People's Court plans to formulate civil compensation judicial interpretations for insider trading and market manipulation, which is expected to enhance accountability and investor protection in the securities market [1]. Group 1: Judicial Interpretations - The introduction of civil compensation judicial interpretations aims to fill the gap in the accountability system for insider trading and market manipulation, unifying judicial standards and improving investor rights [1]. - The Supreme Court has indicated that the interpretations will provide clear rules for investor claims and judicial proceedings, further tightening the legal framework in the capital market [1]. Group 2: Challenges in Civil Compensation - Historically, civil compensation for insider trading has been rare, with most cases resulting in plaintiffs losing or withdrawing their claims, primarily due to difficulties in proving the causal relationship between losses and insider trading [2]. - The challenges in civil compensation cases include establishing causality, defining eligible plaintiffs, and calculating damages, which are key focuses for the upcoming judicial interpretations [2][3]. Group 3: Successful Cases and Legal Framework - There have been successful cases in market manipulation civil compensation, such as the Hengkang Medical case, which marked a breakthrough in this area, followed by other successful cases [2]. - The upcoming judicial interpretations are expected to create a "three-dimensional" accountability system for insider trading and market manipulation, achieving both punishment for violators and compensation for victims [4]. Group 4: Impact on Investors and Judicial Efficiency - The new civil compensation judicial interpretations are anticipated to resolve the issue of "having rights but no recourse" for investors, as previous standards for insider trading and market manipulation were unclear [4]. - The interpretations will standardize judicial decisions, enhance judicial credibility, and improve the efficiency of trials by clarifying standards and methods for damage calculation [4].